retatrutide what is retatrutide clinical trials Reta trial data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 for metabolic health — targeting GLP-1, GIP Retatrutide: What It Is &

Accessed August 2024 at Richard JE, Anderberg RH, Lopez-Ferreras L, et al

Both approaches produce equivalent long-term results, with the conservative schedule offering fewer GI side effects during the escalation period

Contamination screening protects patient health and safety

Due to the metabolic regulatory function of GLP-1RAs, they have also been considered for the treatment of other diseases such as obesity, liver disease and other metabolic dysfunction diseases (22)

The use of metformin in women with polycystic ovary syndrome: an updated review

Rohner said in an April TikTok that she was "willing" to refund anyone who purchased one of her classes within the last 11 months